Skip to main navigation Skip to search Skip to main content

DOMINANCE OF ST131, B2, BLACTX-M-15, AND PAPA-PAPC-KPSMII-UITA AMONG ESBL ESCHERICHIA COLI ISOLATED FROM BLOODSTREAM INFECTIONS IN QUITO, ECUADOR: A 10-YEAR SURVEILLANCE STUDY (2009–2019): a 10-year surveillance study (2009–2019)

  • Jeannete Zurita
  • , Gabriela Sevillano
  • , Ariane Paz Y Miño
  • , Nathalí Haro
  • , Marco Larrea-Álvarez
  • , Iliana Alcocer
  • , David Ortega-Paredes

Research output: Contribution to journalArticlepeer-review

Abstract

Aims: This study aimed to examine antibiotic resistance and the epidemiology of extended-spectrum β-lactamases (ESBL)-producing Escherichia coli associated with bloodstream infections over a period of 10 years. Methods and results: Isolates were collected from January 2009 to December 2019 and those testing for E. coli were included. Antibiotic susceptibility was tested using the VITEK® system. Selected isolates were further characterized by amplification of marker genes (virulence traits, phylogroups, and sequence types). A total of 166 ESBL-producing E. coli were recovered. The blaCTX-M-15 allele was the most abundant. Most of the isolates were resistant to ceftriaxone, cefepime, ceftazidime, ampicillin/sulbactam, piperacillin/tazobactam, and ciprofloxacin. No resistance to carbapenems was registered. More than 80% of bacteria were classified as extraintestinal pathogenic E. coli (ExPEC), and the combination of virulence traits: papA-papC-kpsMII-uitA was the most common. Phylogroup B2 was the most prevalent, and bacteria predominantly belonged to ST131. Conclusions: There was an increase in the ExPEC ESBL-E coli in bloodstream infections and the relationship between the isolates found in these infections during these 10 years.

Original languageEnglish
Article numberlxad269
JournalJournal of Applied Microbiology
Volume134
Issue number11
DOIs
StatePublished - 16 Nov 2023

Bibliographical note

Publisher Copyright:
© The Author(s) 2023. Published by Oxford University Press on behalf of Applied Microbiology International. All rights reserved.

Funding

The authors are grateful to Microbiology and Tuberculosis Deparment of Vozandes Hospital. A special thanks to Dr Jose Luis Recalde and Dr Camilo Zurita-Salinas. Part of this work was presented in Paris, France at the ECCMID Meeting in April, 2020. This study was supported by the grant QINV0213-IINV533010100 of the Pontificia Universidad Católica del Ecuador and the grant MIC-012 of the Department of Biomedical Research from Zurita & Zurita Laboratories.

FundersFunder number
Zurita & Zurita Laboratories
Pontifical Catholic University of EcuadorMIC-012

    Keywords

    • BSI
    • E. coli
    • ST131
    • bla
    • surveillance

    Cite this